Medical CBD for Alcohol Craving & Relapse Prevention — Switzerland 2026
CBD modulates the reward system and reduces craving. Add-on to naltrexone/acamprosate and psychotherapy — no THC in addiction.
~250,000 people in Switzerland live with alcohol dependence. Standard: naltrexone, acamprosate, disulfiram, psychotherapy. CBD reduces craving and relapse risk in preclinical and first clinical studies (Turna 2019, Hurd 2019). CBD isolate/broad spectrum ONLY — THC is contraindicated in addiction. Members: 50 CHF instead of 190.
What the studies show
Turna 2019 (Front Pharmacol review): CBD reduces craving in multiple preclinical alcohol and opioid models.
Hurd 2019 (Am J Psychiatry): CBD 400–800 mg/day reduces craving and anxiety in opioid-dependent — extrapolatable to alcohol.
Preparations & dosing
PURE CBD isolate/broad spectrum (THC <0.05 %): 200–600 mg/day in 2–3 doses.
NO THC — may trigger addictive behavior and cross-tolerance.
Save as a CannabisClub member
Addiction medicine cannabis consultation: 220–300 CHF. Members: 50 CHF flat (pure CBD prescriptions only). Registration free.
FAQ
Can I take regular cannabis?
No. In alcohol dependence strictly CBD isolate/broad spectrum without THC — otherwise addiction transfer.
What does membership save?
50 CHF instead of 190 CHF per consultation. Registration free.
Does insurance cover it?
No — CBD in addiction medicine is not a standard art. 71a indication. Out of pocket.
CBD for Alcohol Craving & Relapse Prevention — Switzerland 2026 (Members 50 CHF)